PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.68%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.25%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-16.28%
Negative EBIT growth while ON is at 5.23%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-15.24%
Negative operating income growth while ON is at 5.23%. Joel Greenblatt would press for urgent turnaround measures.
-14.95%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-12.50%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-13.75%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.46%
Share reduction while ON is at 0.02%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.88%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.31%
Dividend reduction while ON stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-61.75%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-66.59%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
42.07%
10Y revenue/share CAGR under 50% of ON's 84.90%. Michael Burry would suspect a lasting competitive disadvantage.
2.81%
5Y revenue/share CAGR above 1.5x ON's 0.42%. David Dodd would look for consistent product or market expansions fueling outperformance.
14.67%
3Y revenue/share CAGR under 50% of ON's 34.69%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
54.64%
10Y OCF/share CAGR at 75-90% of ON's 71.94%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
22.90%
Positive OCF/share growth while ON is negative. John Neff might see a comparative advantage in operational cash viability.
67.10%
3Y OCF/share CAGR 1.25-1.5x ON's 46.92%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
91.38%
Positive 10Y CAGR while ON is negative. John Neff might see a substantial advantage in bottom-line trajectory.
23.77%
Positive 5Y CAGR while ON is negative. John Neff might view this as a strong mid-term relative advantage.
116.01%
3Y net income/share CAGR above 1.5x ON's 73.54%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
37.06%
Below 50% of ON's 600.57%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
7.25%
Below 50% of ON's 18.99%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-1.77%
Negative 3Y equity/share growth while ON is at 30.23%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
1156.44%
Dividend/share CAGR of 1156.44% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
190.22%
Dividend/share CAGR of 190.22% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
81.56%
3Y dividend/share CAGR of 81.56% while ON is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
8.93%
AR growth well above ON's 0.42%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.74%
Inventory growth well above ON's 1.24%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-3.35%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-1.19%
We have a declining book value while ON shows 2.81%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.05%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
5.23%
R&D growth drastically higher vs. ON's 7.69%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
8.89%
We expand SG&A while ON cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.